Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Long-Term Investments (2021 - 2022)

HealthLynked (HLYK) has disclosed Long-Term Investments for 2 consecutive years, with $300600.0 as the latest value for Q4 2022.

  • On a quarterly basis, Long-Term Investments fell 79.34% to $300600.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $300600.0, a 79.34% decrease, with the full-year FY2022 number at $300600.0, down 79.34% from a year prior.
  • Long-Term Investments was $300600.0 for Q4 2022 at HealthLynked, up from $255000.0 in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $1.5 million in Q4 2021 to a low of $165000.0 in Q1 2022.